Vagal Stimulation in POTS
NCT: NCT03124355 · ACTIVE_NOT_RECRUITING
Brief Summary
The purpose of this study is to investigate how the electrical stimulation of a nerve in the skin of the earlobe (transcutaneous vagal nerve stimulation), alone or in combination with two medications (galantamine and pyridostigmine), affects the way the autonomic (involuntary) nervous system controls heart rhythm, symptoms on standing, and inflammatory markers in female patients with postural tachycardia syndrome (POTS). The study consists of 2 parts: a screening (1-2 study days), and 3 testing days. The study will take 5 days total and about 16 participants will be screened for the study. The investigators estimate 13 will be eligible to participate in all of the study days.
Frequently Asked Questions
What is Vagal Stimulation in POTS?
Vagal Stimulation in POTS is a clinical trial registered under NCT03124355. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT03124355?
The current status of NCT03124355 (Vagal Stimulation in POTS) is: ACTIVE_NOT_RECRUITING.
When did Vagal Stimulation in POTS start?
Vagal Stimulation in POTS started on 2017-09-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.